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The N-Terminus of Nef from HIV-1/SIV
Associates with a Protein Complex
Containing Lck and a Serine Kinase
Andreas S. Baur,* Gabriele Sass,* Bernd Laffert,* level remains to be determined. To date, at least three
functions for Nef have been described. First, Nef leadsDieter Willbold,² Cecilia Cheng-Mayer,³
and B. Matija Peterlin§ to the rapid endocytosis of CD4 from the surface of
infected or transfected cells. The implication of this ef-*Institut fuÈ r Klinische und Molekulare Virologie
UniversitaÈ t Erlangen/NuÈ rnberg fect of Nef is not clear. The virus could, for example,
block superinfection of cells by reducing the number of91054 Erlangen
Federal Republic of Germany receptors on the surface or, alternatively, modulate T
cell activation pathways through increased levels of free²Lehrstuhl fuÈ r Struktur und Chemie der Biopolymere
UniversitaÈ t Bayreuth Lck in the cytoplasm (Rhee and Marsh, 1994; Aiken et
al., 1994). Second, Nef was reported to increase viral95440 Bayreuth
Federal Republic of Germany infectivity in vitro in a single cycle infection assay (Miller
et al., 1994). This report confirmedother studies showing³Aaron Diamond AIDS Research Center
New York, New York 10016 higher levels of viral replication in T cells with nef-com-
petent HIV as compared with their nef-deleted counter-§Howard Hughes Medical Institute
University of California, San Francisco parts (Spina et al., 1994; Chowers et al., 1994; Zazo-
poulos and Haseltine, 1993). Based on mutationalSan Francisco, California 94143-0724
analysis, down-regulation of CD4 and increase of viral
infectivity were mapped to different regions of the mole-
cule (Saksela et al., 1995; Goldsmith et al., 1995). Third,Summary
Nef modulates T cell activation pathways. Stable ex-
pression of Nef in T cell lines perturbed T cell receptorThe Nef protein of human and primate lentiviruses is
(TCR)-mediated activation of numerous cellular factors,a key factor in HIV/SIV pathogenesis. Here we report
including NF-kB and interleukin-2 (Greenway et al.,that Nef associates with two different kinases, forming
1995; Niederman et al., 1992; Luria et al., 1991). Thea multiprotein complex at the far N-terminus of the
inhibition of T cell signaling seems to depend on theviral protein. One of the kinases was identified as Lck,
subcellular localization of Nef as shown with a CD8±Nefwhereas the second protein was found to be a serine
chimeric fusion protein stably expressed in Jurkat cells.kinase that phosphorylated Nef and Lck in vitro and
In these cell lines, CD8±Nef was almost exclusivelycould be discriminated from the serine kinase iden-
found in the cytoplasm, which correlated with inhibitiontified previously. The Nef-associated kinase com-
of TCR-mediated induction of tyrosine phosphorylationplex (NAKC) was demonstrated in COS cells, in HIV-
and Ca21 mobilization. Cells with higher levels of CD8±infected cells, and in vitro using recombinant Lck and
Nef at the plasma membrane, however, not only hadNef proteins. Deletion of a short amphipathic a-helix
restored signaling pathways, but were found to be acti-in the N-terminus, which was found to be conserved
vated T cells (Baur et al., 1994). In line with these results,in all Nef proteins, inhibited association of the NAKC
a SIV Nef allele was recently identified exhibiting pro-and significantly reduced virion infectivity.
found effects on T cell activation and cell transformation
(Du et al., 1995).Introduction
To understand the multiple effects of Nef, identifica-
tion of proteins that associate with Nef is critical. UntilThe genomes of the human and simian immunodefi-
now, numerous cellular factors have been implicated inciency viruses (HIV and SIV) encode an unusually high
binding to Nef, among them two different kinase fami-number of regulatory genes (tat, rev, vif, vpu, nef, vpr,
lies. In studies with transfected and infected cell lines,and vpx in HIV-2 and SIV) and thus are considered com-
a serine kinase was reported to coprecipitate with Nefplex retroviruses (for review see Subbramanian and Co-
of HIV and SIV (Sawai et al., 1994, 1995). In other reports,hen, 1994; Cullen, 1995). Four of these genes, vif, vpu,
using recombinant proteins, the tyrosine kinases Lck,vpr, and nef, are dispensable for virus replication in a
Hck, and Lyn associated with Nef (Collette et al., 1996;number of in vitro systems and were therefore termed
Greenway et al., 1995; Saksela et al., 1995). Both kinaseªnonessentialº (for review see Trono, 1995). In the in-
families were found to bind the more conserved centralfected host, however, the nef gene appears to be a key
part of Nef. The role of either kinase family in the abovefactor in the pathogenesis of SIV/HIV infection. This is
described functions of Nef, however, is unclear. In thisbased on studies in Rhesus monkeys, which upon infec-
study, we report that the N-terminus of Nef associatestion with nef-deleted strains of SIV did not develop high
with a protein complex (referred to as NAKC, for Nef-virus loads or progress to AIDS (Kestler et al., 1991).
associated kinase complex) containing Lck and a serineThe importance of Nef in the virus pathogenesis was
kinase that is distinct from the PAK-related kinase de-further supported by the discovery of deleted nef genes
scribed recently (Sawai et al., 1994; Lu et al., 1996).in HIV-infected, long-term nonprogressing individuals
Our results suggest that the NAKC is required for Nef-(Deacon et al., 1995; Kirchhoff et al., 1995).
mediated increase of viral infectivity and therefore theAlthough the importance of Nef for the viral life cycle




A Kinase Activity Associates
with the N-Terminus of Nef
In previous studies on the effects of Nef on T cell signal-
ing (Baur et al., 1994; Sawai et al., 1994, 1995), we ex-
pressed a CD8±Nef chimera (SF2 strain) in T and COS
cells. In these studies we found that Nef associated
specifically with a serine kinase (Sawai et al., 1994).
Characteristically, this kinase did not bind to N-terminal
fragments of Nef (Sawai et al., 1995). An example of
these results is shown in Figure 1A, lanes 1±3. Full-
length CD8±Nef (CN), as well as a truncated form of Nef
encoding the first 94 amino acids (CN.94) and truncated
CD8 (CT), consisting of the extracellular and transmem-
brane part of CD8, were transfected into COS cells. After
2 days, the chimeras were immunoprecipitated with
anti-CD8 and in vitro kinase assays were performed. As
shown in lane 2 of Figure 1A, a single band of molecular
mass 62 kDa (p62) was detected with the full-length CN
chimera, representing the kinase itself or a substrate
(Sawai et al., 1994). No activity was detected with the
truncated Nef construct (Figure 1A, lane 3). We repeated
this experiment using Mn21 instead of Mg21 in the kinase
buffer. As shown in Figure 1A, lanes 4±6, in addition to
p62 a second band of about 53 kDa was detected using
the full-length CN chimera (lane 5, open arrow), and a
single prominent band was observed with CN.94 (lane
6, closed arrow). Other bands visible in Figure 1A (lanes
Figure 1. N-Terminal Fragments of Nef Associate with Two Different5 and 6) are probably nonspecific. To confirm that the
Kinase Activities in COS and T Cellssame amounts of CN chimeras were expressed, we blot-
(A) In vitro kinase assay and Western blot of CD8±Nef (CN) chimerasted the immunoprecipitates from Figure 1A with an anti-
transfected into COS cells. Two different CN chimeras and a CD8Nef rabbit serum. In Figure 1B, the expected Nef bands
control were transfected into COS cells, immunoprecipitated with
at around 53 kDa (CN, lanes 2 and 5) and 42 kDa (CN.94, an anti-CD8 MAb, and subjected to an in vitro kinase assay (IVKA)
lanes 3 and 6) are shown. The additional bands in the using Mg21 or Mn21 cations in the kinase buffer. After separation
Mn21-based kinase assay (Figure 1A, lanes 4±6) comi- by 12.5% SDS±PAGE, the immunoprecipitates were transferred onto
nitrocellulose. CT (CD8 truncated) was used as control; CN encodesgrated with the Nef bands in Figure 1B (compare open
the full-length Nef protein, and CN.94 encodes the N-terminal 94and closed arrows in Figures 1A and 1B). These results
amino acids of Nef.implied that the CN chimeras were phosphorylated by
(B) Western blot analysis of (A). The immunoprecipitates described
a second kinase, which associated with the N-terminus in (A) were blotted with an anti-Nef serum. Note that bands in lane
of Nef. 5 of (A) and (B) migrate with the same mobility (open arrows), as
well as bands in lane 6 of (A) and (B) (closed arrows).
(C) IVKA with Lck (lane 1) and different CN chimeras (CN.47 and
In T Cells Lck and a Second Kinase Associate CN.94, lanes 3 and 4) after immunoprecipitation (IP) from Jurkat (J.)
cell lines. For control, CT and CN.47/211, coding for the C-terminalwith the N-Terminus of Nef
47±211 amino acids of Nef, were used (J.CT, lane 2; J.CN.47/211,Following immunoprecipitation and in vitro kinase
lane 5). CN.47 and CN.94 associate with a protein of same molecularassays, N-terminal subfragments of Nef derived from
mass as Lck, indicated by an arrow. The lower bands in lanes 3 and
stable Jurkat cell lines were also found to be phosphory- 4 represent phosphorylated CN.47 and CN.94, respectively.
lated. As shown in Figure 1C, kinase reactions with (D) Reimmunoprecipitation of Lck with a specific antibody from in
CN.49 and CN.94, coding for the N-terminal 49 and 94 vitro kinase reactions shown in (C). Each lane in (C) corresponds to
the respective lower lane in the panel. Lck could be reimmunopre-amino acids of Nef, revealed thepresence of phosphory-
cipitated from in vitro kinase reactions with Lck (serving as positivelated bands corresponding to the molecular mass of the
control), CN.47, and CN.94 (lanes 1, 3, and 4).chimeras (lanes 3 and 4). In addition, a protein with a
(E) In vitro kinase reaction with a short CN chimera (CN.94) immuno-
molecular mass comparable with Lck (56±60 kDa) was precipitated from Jurkat (J.CN.94, lane 2), J.CaM.1 (J.CaM.1.CN.94,
coprecipitated (Figure 1C, lanes 3 and 4). For compari- lane 3), and J.CaM.1 cells reconstituted with lck (J.CaM.1/lck.CN.94,
son, Lck was immunoprecipitated from Jurkat control lane 4). The lower bands in lanes 2±4 represent phosphorylated
CN.94.(J.CT) cells and subjected to the same in vitro kinase
assay (Figure 1C, lane 1). The 60 kDa protein was not
observed in immunoprecipitates of truncated CD8 (Fig-
ure 1C, lane 2, CT) or a control CN construct coding for immunoprecipitates shown in Figure 1C were reimmu-
noprecipitated with a Lck-specific antibody. As shownthe C-terminal 47±211 amino acids of Nef (lane 5, CN.47/
211). To ascertain the identity of the 60 kDa band, the in Figure 1D, Lck was found in immunoprecipitates of
Association of Kinases with HIV/SIV Nef
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Lck itself (lane 1), serving as positive control, as well as
in CN.49 and CN.94 (lanes 3 and 4). Thus, the 60 kDa
band was identified as Lck. To determine whether the
short CN chimeras were phosphorylated by Lck, CN.94
was expressed in J.CaM.1 cells, which lack expression
of Lck (Straus and Weiss, 1992) and in J.CaM.1 cells
reconstituted with lck (J.CaM.1/lck; Straus and Weiss,
1992). After obtaining stable cell lines, CN.94 was immu-
noprecipitated and subjected to an in vitro kinase assay.
As shown in Figure 1E, Lck association was seen in
Jurkat (lane 2) and J.CaM.1/lck cells (lane 4), but not in
J.CaM.1 cells (lane 3). Since CN.94 was phosphorylated
in the absence of Lck in T cells (lane 3) and in COS cells
(Figure 1), we have concluded that a second kinase
associates with the N-terminus of Nef independent of
the presence of Lck.
Lck and a Serine Kinase Colocalize
at the N-Terminus of Nef
To map the binding site of both kinases, stable Jurkat
cell lines were established with several deletion mutants
of CN, coding for the N-terminal 94, 49, 35, 26, 22, 20,
and 15 amino acids of Nef. Truncated CD8 (CT) and a
CN chimera encoding amino acids 47±105 were used
as controls. The subfragments of Nef were immunopre-
cipitated and subjected to in vitro kinase assays as de-
scribed above. These experiments revealed that a chi-
mera as short as CN.22 still bound both kinases (Figure
2A, lane 6), whereas CN.20 or CN.15 (Figure 2, lanes 7 Figure 2. Binding and Characterization of Kinase Activities Associ-
and 8) or any of the controls (Figure 2, lanes 1 and 9) ating with the N-Terminus of Nef
did not. To confirm that all constructs were expressed (A) Increasingly shorter forms of CD8±Nef were immunoprecipitated
from Jurkat cell lines, and in vitro kinase assays were performed asat comparable levels, the respective stable cell lines
described in Figure 1. The constructs ranged from amino acid 94(J.CN.94 to J.CN.45/105) were metabolically labeled
(CN.94, lane 2) to amino acid 15 (CN.15, lane 8). For control, CTwith 35S and the CN chimeras were immunoprecipitated
(CD8 truncated) was used (lane 1) and CN.49/105, expressing amino
with anti-CD8 (Figure 2B). acids 49±105 of Nef, was fused to truncated CD8 (lane 9).
Next, the phosphorylated amino acid residues in Lck (B) To demonstrate comparable levels of expression of all constructs
and phosphorylated CN.47 (shown in Figure 2A, lane 3) described in (A), cell lines were metabolically labeled with 35S and
immunoprecipitated with anti-CD8. The sequence at the bottom ofwere identified. For this purpose, the in kinase reactions
the figure shows the N-terminal 31 amino acids of Nef (SF2), indicat-were transferred to nitrocellulose, from which both
ing by arrows where Nef was truncated in CN.20 and CN.22.bands were excised (indicated by arrows) and subjected
(C) Phosphoamino acid analysis (PAA) of the upper (Lck) and lowerto phosphoamino acid analyses. As shown in Figure 2C,
band (CN.47) also shown in lane 3 of (A). Lck is phosphorylated on
we found Lck to be phosphorylated on a tyrosine as a tyrosine and serine residue, whereas CN.47 was only phosphory-
well as on a serine residue, whereas CN.47 was only lated on serine. The positions of unlabeled phospho-serine (S),
phospho-threonine (T), and phospho-tyrosine (Y) are indicated.phosphorylated on a serine residue. The tyrosine phos-
phorylation was likely to be the result of the autophos-
phorylation activity of Lck, as described elsewhere
(Straus and Weiss, 1992). The serine phosphorylation Lck, or Fyn resulted in Nef phosphorylation and binding
was obviously due to the associating serine kinase, of p62 and Lck, but not Fyn (lanes 2±4, see arrows).
which phosphorylated both Lck and CN.47. Taken to- Interestingly, the band representing Nef shifted upon
gether, these results indicated that both kinase activities cotransfection with Lck but not Fyn (Figure 3A, lanes 3
colocalized at the N-terminus of Nef. and 4), suggesting that nef.4-AU, unlike CN.47 (see Fig-
ure 2), was phosphorylated by Lck. These results indi-
cated that association of Nef with the N-terminal kinaseBinding of Nef to the N-Terminal Kinase
complex (NAKC) can occur simultaneously to the bind-Complex and p62
ing of p62. For further confirmation, SIVmac239-Nef wasTo ascertain whether phosphorylation of full-length Nef
cotransfected with mock DNA or Lck (Figure 3A, lanesas well as binding to Lck and p62 occur simultaneously,
5 and 6) into COS cells and immunoprecipitated witha C-terminal-tagged (AU-1) Nef allele (nef.4-AU) derived
an anti±SIV Nef antibody. Phosphorylation of SIV Nef,from uncultured peripheral blood mononuclear cells
binding of Lck, and p62 was observed as in nef.4-AU.(PBMC) of an HIV-infected individual, was investigated
(Figure 3A, lane 6). As in HIV-1 Nef, the N-terminus ofin COS cells and in vitro kinase assays. As shown in
Figure 3A, cotransfection of nef.4-AU with mock DNA, SIV Nef was phosphorylated and bound to Lck, as could
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otide coding for an AU-1 tag plus a stop codon into the
Xhosite of the nef allele of an HIV-1 proviral clone (NL4-3;
see the bottom of Figure 3), creating a 37 amino acid
N-terminal fragment of Nef. We used this strategy for
two reasons: first, we wanted todissect N-terminal bind-
ing of Lck to Nef from a potential binding to the con-
served central part as reported recently (Collette et al.,
1996), and, second, N-terminal fragments of Nef, but
not the full-length Nef protein, are readily expressed at
the plasma membrane of Jurkat cells where Lck is lo-
cated (Baur et al., 1994). Jurkat cells were permanently
infected with the recombinant (NL4-3.nef.37.AU) and the
wild-type NL4-3 virus without AU-1 tag, serving as con-
trol (NL4-3.nef.wild-type). Cytoplasmic lysates equiva-
lent to 4 3 106 cells from each cell line were immunopre-
cipitated with anti-AU-1 or a nonspecific rabbit serum
and subjected to an in vitro kinase reaction. An aliquot
of the reaction (one tenth) was separated by 15% SDS±
polyacrylamide gel electrophoresis (SDS±PAGE) (Figure
3B), whereas the remainder of the reaction was reimmu-
noprecipitated with a specific antibody against Lck. As
shown in Figure 3C, Lck could be reimmunoprecipitated
from the in vitro reactions at significant levels (lane 3,
see upper arrow). Along with Lck, a second band was
observed (see open arrow in Figure 3C), probably repre-
senting the phosphorylated N-terminal fragment of Nef.
This short fragment was also seen as a faint signal in
the initial immunoprecipitation (see arrow in Figure 3B).
For comparison, Lck was immunoprecipitated from Jur-
kat cells and subsequently reimmunoprecipitated in the
Figure 3. Phosphorylation of Nef and Association with Lck in COS
same manner (Figure 3C, lane 4).and HIV-Infected Cells
(A) In vitro kinase assay (IVKA) with a C-terminal-tagged (AU-1),
primary Nef protein (Nef.4-AU), nonfused SIVmac239-Nef, and a CN Assembly of the Nef-Associated Kinase Complexchimera coding for the first 50 amino acids of SIVmac239-Nef, cotrans-
In Vitro with Recombinant Proteins andfected with mock DNA (lanes 2, 5, and 8), Lck (lanes 3, 6, and 7),
or Fyn (lane 4) into COS cells. Prior to IVKAs, Nefwas immunoprecip- Cytoplasmic Lysates of Jurkat Cells
itated with a nonspecific rabbit serum (NRS, lane 1), anti-AU-1 (lanes Next, we asked whether the Nef-associatedkinase com-
2±4), anti±SIV Nef serum (lanes 5 and 6), or anti-CD8 (lanes 7 and plex could be assembled in vitro, using baculovirus-
8). The position of p62 (Sawai et al., 1994), Lck, and phosphorylated
derived glutathione S-transferase (GST)±Lck and pro-Nef are indicated by arrows and bracket.
karyotically expressed Nef. Along with an unrelated(B) IVKA after immunoprecipitation of N-terminal Nef fragments from
protein (up), serving as control, the nef.4 allele was ex-HIV-infected cells. As depicted at the bottom of (B) and (C), an
oligonucleotide encoding an AU-1 tag and a stop codon was intro- pressed and purified using the pET system (Novagen).
duced into the XhoI site of the nef reading frame from the NL4-3 In Figure 4A, aliquots of the purified proteins (13 mg) are
provirus (NL4-3.nef.37. AU). Cells infected with NL4-3.nef.37.AU shown in a Coomassie-stained 15% SDS±polyacryla-
(nef.37.AU) or wild-type NL4-3 (nef.wt) were lysed and immunopre- mide gel. To assemble the complex, 1 mg of GST±Lck
cipitated with anti-AU-1 (lanes 1 and 3) or a nonspecific rabbit serum
and 5 mg of recombinant Nef or up were incubated in the(NRS, lane 2). Kinase reactions were analyzed by 15% SDS±PAGE.
presence of bovine serum albumin (BSA) or cytoplasmicThe position of theputative phosphorylated N-terminalNef fragment
(46 amino acids) is indicated by an open arrow in (B) and (C). lysates from Jurkat or Sf9 cells as indicated in Figure 4B.
(C) Reimmunoprecipitation of Lck with a specific MAb from kinase After the incubation, GST±Lck was immunoprecipitated
reactions described in (B). For comparison, Lck was immunoprecipi- and an in vitro kinase assay was performed. As seen in
tated from Jurkat cells and subsequently reimmunoprecipitated in
Figure 4B, GST±Lck coimmunoprecipitated with a phos-an analogous way (lane 4). The Lck signal of the control (lane 4) is
phorylated Nef protein, and probably with N-terminalless intense since we used lysates from only 5 3 106 uninfected as
fragments of Nef (indicated by an asterisk; see alsocompared with 40 3 106 infected cells (lanes 1±3) for immunoprecipi-
tation. Figure 4A), in the presence of Jurkat lysates (lane 4),
but not in the presence of BSA (lane 2) or Sf9 lysates
(lane 6). No association or a nonspecific phosphorylationbe shown in cotransfections with a CN chimera, encod-
activity was seen with the unrelated protein (Figure 4B,ing for the first 50 amino acids of SIVmac239-Nef (CN.50,
lanes 3 and 5). Phosphoamino acid analysis with theFigure 3A, lanes 7 and 8).
phosphorylated Nef protein revealed the same result as
in Figure 2, namely that Nef was phosphorylated mainlyAssociation of Lck with the N-Terminus
on a serine residue(s) (data not shown). Usingthis exper-of Nef in Infected Cells
imental approach, we did not see an association withTo demonstrate the association of Lck with the N-termi-
nus of Nef in infected cells, we introduced an oligonucle- p62. Likewise, incubation of baculovirus-derived Nef
Association of Kinases with HIV/SIV Nef
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Figure 4. Association of Recombinant Nef and Lck Proteins In Vitro
(A) Coomassie staining of prokaryotically expressed and purified
Nef.4 and an unrelated protein (up). The asterisk indicates probable
degradation products of Nef, which could not be removed by the
purification process.
(B) In vitro kinase assay after immunoprecipitation of GST±Lck,
which was incubated with Nef (nef.4) in the presence of lysis buffer
(lane 1), BSA (lane 2), Jurkat lysate (Ju.lyst., lane 4), or lysate from
Sf9 cells (Sf9.lyst., lane 6). Similarly, GST±Lck was incubated with
a control protein in the presence of Jurkat (lane 3) or Sf9 cellular
lysate (lane 5) prior to the kinase reaction. Owing to the short expo-
sure, autophosphorylation of GST±Lck (see arrow) was low.Associa-
tion and phosphorylation of Nef was only seen in the presence
of Jurkat lysates (lane 4). Phosphorylated bands indicated by the
asterisk probably represent N-terminal fragments of Nefas indicated
in (A) (see the same asterisk in [A]).
proteins with Jurkat lysates did not reveal binding of Upon cotransfection with Lck, both mutants had a re-
duced capacity to bind the tyrosine kinase (Figure 6B,p62 (data not shown). In conclusion, these results dem-
onstrated that the binding of Lck to Nef as well as the compare lanes 3±5); however, they were not completely
unable to do so. The latter result prompted us to reevalu-phosphorylation of Nef required at least a third factor,
which was present in cytoplasmic lysates of T but not ate whether, in COS cells, parts of Nef other than the
N-terminus would contribute to the binding of Lck. AsSf9 cells.
demonstrated in Figure 6C, in COS cells, but not in T
cells (see Figure 1C), CN.47±211 still associated withThe NAKC Is Required for Increased
Viral Infectivity Lck, although to a much lesser degree than the N-termi-
nus of Nef represented by CN.47 (Figure 6C). A possibleNext, we evaluated the functional relevance of the NAKC
for viral replication. The N-terminus of HIV-1 Nef shows mechanism for this interaction will be discussed below.
Like the wild-type SF2 Nef protein, both mutants (with-considerable heterogeneity and has almost no homol-
ogy to Nef of SIVmac239. Moreover, it was found to be a out CD8 tag) down-regulated CD4 after cotransfection
into COS cells (Figure 7A). For comparison and control,separate domain (residues 1±57 in HIV-1 NL4-3; Freund
et al., 1994a, 1994b), distinguishable from the more con-
served C-terminal part of Nef. However, the amino acids
16±22 (SF2:IRERMRR) are well preserved in HIV-1
strains. Among HIV-2/SIV strains the corresponding re-
gion issimilarly preserved and resembles the HIV-1 motif
(SIV/HIV-2cons:LRERLLRAR). We therefore analyzed the
N-termini (amino acids 1±57) of 42 randomly selected
HIV and SIV Nef sequences for possible secondary
structure similarities, applying the PhD network (Rost
and Sander, 1993). In all cases, an overall basic charge
and an amphipathic a-helical structure was predicted
for residues 14±21 (Figure 5). In view of this finding, the
IRERMRR motif was deleted, and the resulting clone
(CN.D16±22 or untagged D16±22) was subsequently
tested for Nef phosphorylation, p62/Lck binding, and
CD4 down-regulation. In a second clone, we introduced
a larger deletion in the N-terminus (amino acids 11±40
and D11±40) to determine whether additional domains
upstream and downstream of the IRERMRR motif would
Figure 5. Clustal V Multiple Sequence Alignment of HIV and SIV Nef
affect the function of Nef. As shown in Figure 6A, both Proteins
mutants (CN fusion proteinsCN.D16±22; CN.D11±40) still
Sequences were obtained from the SwissProt data bank. Secondary
bound p62 but were not phosphorylated like the wild- structure prediction using the PhD network (Rost and Sander, 1993)
type CN (compare lanes 1 with 2 and 3; for the identity for 42 randomly selected HIV and SIV Nef sequences (only 9 are
shown) in all cases predicted an a-helical structure for residuesof the phosphorylated band, indicated by P-CN and an
14±21 (boxed). For this region no deletions or insertions occur inarrow in lane 1, see also Figures 1A and 1B). Consistent
any of the Nef amino acid sequences. Owing to the conservedwith the idea of a protein complex binding to the
spacing of the hydrophobic residues 16 and 20 (bold), the amphi-N-terminus of Nef, several additional phosphorylated
pathic character of the predicted helix is retained in all Nef proteins.
bands, which are usually observed in kinase assays with Another feature of region 14±21 in all Nef sequences is its overall
Nef, were absent with both mutants (compare lanes 1 basic charge. In addition, we show the sequences of Nef.4 and
SIVmac239.with 2 and 3 in Figure 6A and lanes 3±5 in Figure 6B).
Immunity
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Figure 6. The N-Terminal Nef Mutants Bind
p62 but Not the NAKC
(A) In vitro kinase assay (IVKA) of CN and
mutant CN chimeras with N-terminal dele-
tions (CN.D16±22 and CN.D11±40) after anti-
CD8 immunoprecipitation(IP) from COS cells.
CN (lane 1), but not mutant CN chimeras
(lanes 2 and 3), were phosphorylated (P-CN
and arrow) and associated with additional
phosphorylated proteins. In contrast, all CN
constructs associated with p62 (arrow).
(B) IVKA after anti-CD8 immunoprecipitation
of control CT (lane 1), CN (lane 3), and CN
mutant chimeras (CN.D16±22 and CN.D11±
40, lanes 4 and 5) cotransfected with Lck into
COS cells. For comparison, Lck was immuno-
precipitated (lane 2). The mutantCN chimeras
showed a reduced binding to Lck (lanes 4
and 5).
(C) IVKA after anti-CD8 immunoprecipitation of CN.47 and CN.47±211 cotransfected with (lanes 2 and 4) or transfected without Lck (lanes 1
and 3) into COS cells. In comparison with the N-terminus (CN.47, lane 2), the C-terminus of Nef (CN.47±211, lane 4) showed a significantly
reduced association with Lck.
a primary Nef variant was used, which was obtained kinase could be identified as Lck, the serine kinase was
found to phosphorylate Nef as well as Lck in vitro. Thefrom uncultured PBMC (Figure 7A, nef.11) and repeat-
edly showed a reduced ability to down-regulate CD4 in NAKC could be demonstrated in COS cells, in infected
cells, and in vitro by incubating recombinant Lck and Neftransient assays. Finally, both mutants were cloned into
a proviral background (NL4-3). The resulting clones, with Jurkat cytoplasmic lysates. Finally, we presented
evidence that the NAKC interacted with a conservedalong with a positive (wild-type SF2/NL4-3) and a nef
negative control (N-terminal deletion in nef), were amphipathic a-helix in the N-terminus of Nef and was
necessary for optimal infection of resting PBMC.transfected into Jurkat cells and infectious supernatants
were collected. Resting PBMC were infected with an The NAKC is clearly distinct from a second set of
cellular factors (p72/74 and p62), including a serine ki-infectious dose equivalent to 2 ng of p24. After 2 days
the cells were stimulated with OKT3, and culture super- nase, reported previously to associate with Nef of HIV
and SIV (Sawai et al., 1994). For binding to Nef the latternatants were collected for 14 days and analyzed for RT
activity. In comparison with the positive control both factors require the conserved central domain (Sawai et
al., 1995; see also Figure 1), whereas the kinase complexmutants showed a delay in detectable viral replication
of about 4 days (Figure 7B), which was an intermediate reported here binds to the far N-terminus of Nef. In
addition, Nef is not phosphorylated by the serine kinasephenotype between the wild type and the nef negative
control. Thus, an intact N-terminus of Nef appeared to described by Sawai et al., and differential binding of
both protein complexes to Nef could be demonstratedbe required for optimal viral infectivity.
in our report (note that the presence of p72/74 and p62
is best observed in T cells). Even after overexpressionDiscussion
in COS cells, it took a sensitive detection system such as
the in vitro kinase assay to demonstrate an associationIn this study we present evidence in support of an inter-
action of Nef with a serine and a tyrosine kinase activity. between Lck and Nef. This could be explained by a
transient, low affinity interaction of both partners, a rate-Binding of both kinases was colocalized to the far
N-terminus of the viral protein, suggesting the formation limiting modification step, or a third or bridging protein
being the limiting factor in these assays. As shown withof a multiprotein complex (NAKC). Whereas the tyrosine
Figure 7. The N-Terminal Nef Mutants Show
a Reduced Viral Infectivity but Maintain the
Ability to Down-Regulate CD4
(A) CD4 expression on the surface of COS
cells after cotransfection of empty vector
DNA (pRcCMV), untagged SF2-Nef (SF2), a
primary Nef variant (nef.11), mutant SF2-pro-
teins (SF2.D16±22 and SF2.D11±40), and a
bGal-expression plasmid (pSVbGal). Values
on top of the bars represent the CD4 expres-
sion in percent of the negative control (CD4
plus pRcCMV), representative of two inde-
pendent experiments with a CD4 surface ex-
pression of at least 60% in the negative
control.
(B) HIV replication after infection of resting PBMC with NL4-3 (wild type [wt]) serving as positive control, NL4-3.D-nef (D-nef) serving as negative
control, and NL4-3 nef mutants (D16±22 and D11±40). At 2 days postinfection, the PBMC were stimulated with OKT3 for 2 days. Data presented
are averages of RT values, assessed in the culture supernatants and obtained from two independent infections.
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recombinant proteins, Lck did not bind directly to Nef appear to bind the more conserved C-terminal portion
(Sawai et al., 1995; Grzesiek et al., 1996). However, thebut required a third factor present in Jurkat but not Sf9
cytoplasmic lysates. This again suggested the formation mutant viral clones displayed a reduced capacity to
infect resting PBMC. This suggested that the associa-of a protein complex at theN-terminus of Nef. The exper-
iment with the recombinant proteins also demonstrated tion of the NAKC with the N-terminal a-helix is important
for Nef function. We did not observe a significant differ-that the NAKC could be formed independently of Nef
myristoylation and membrane targeting, but did not rule ence between the 7 (D16±22) and the 29 (D11±40) amino
acid deletion. Therefore, the a-helix may be the criticalout that association of Nef with the plasma membrane
favored formation of the complex. interacting domain.
Since phosphorylation of the HIV matrix protein p17Despite the considerable sequence heterogeneity in
the N-terminus of all HIV/SIV Nef proteins, secondary greatly increases viral infectivity (Gallay et al., 1995; Buk-
rinskaya et al., 1996), it is reasonable to speculate thatstructure predictions revealed a 7 amino acid overall
basic amphipathic a-helix, which appeared to be con- the kinase complex described here could be required
for this effect. Like p17, Nef is myristoylated, associatesserved in all Nef proteins (Figure 5). Mapping of the
binding site for the NAKC (Figure 2) was leading to the with the plasma membrane, and is incorporated into the
virion. This assumption, however, awaits further confir-same motif. This could explain why, despite the se-
quence heterogeneity, both the N-termini of SIV and mation. Besides increasing viral infectivity, Nef was also
found to increase viral transcription/replication throughHIV-1 Nef bound Lck and were phosphorylated probably
by the same serine kinase. Deletion of the IRERMRR the induction of T cell activation (Baur et al., 1994; Du
et al., 1995). It is possible that Lck, a critical secondmotif in the full-length Nef protein abolished phosphory-
lation of Nef and reduced binding of Lck. In addition, messenger of T cell activation signals, is also involved
in this Nef-mediated effect. Therefore, the NAKC mayseveral phosphorylated bands, usually observed in ki-
nase assays with Nef proteins, were absent with the support viral replication beyond the stage of proviral
integration.mutants. This further suggested that a protein complex
associated with the N-terminal a-helix. Preliminary data
indicate that one of these ªdisappearingº bands of Experimental Procedures
higher molecular mass (between 70 and 80 kDa) is the
Plasmid Constructionssecond kinase itself (Baur et al., 1996). In line with our
The CD8±Nef (SF2) fusion protein was generated by a two-step PCRresults, Bodeus et al. (1995) reported the association of
procedure and cloned into the pRcCMV expression vector (pCN) as
a serine kinase with short N-terminal fragments of Nef, described previously (Baur et al., 1994). To clone shorter forms of
expressed as GST proteins and incubated with cyto- Nef upstream of CD8, a BglII site was introduced into pCN between
plasmic lysates from Jurkat cells. These authors also truncated CD8 and Nef. Resulting constructs were designated pCN
(for CD8±Nef) plus the number of amino acids fused to CD8 (fordescribed the coprecipitation of a phosphorylated 60
example pCN.94). N-terminal deletions (D16±22 and D11±40) werekDa protein, probably representing Lck but not investi-
introduced in SF2-Nef by a two-step PCR procedure as describedgated in detail.
above. Resulting constructs were cloned into the pRcCMV vector
Deletion of the N-terminal a-helix did not completely either with or without the CD8 tag. Resulting clones were designated
abolish binding of Lck. A direct comparison of kinase CN.D16±22 and CN.D11±40 (with CD8 tag) or SF2.D16±22 and
assays with CN.47 and CN.47±211 inCOS cells indicated SF2.D11±40 (without CD8). The nef alleles nef.4 and nef.11 were
obtained from a single HIV-1-infected individual by nested PCRthat regions other than the N-terminus bound to Lck,
from uncultured PBMC. C-terminal-tagged Nef proteins were con-albeit to a much lesser extent (Figure 6). A similar obser-
structed by PCR amplification, including the sequence of the ªAU-1ºvation was made by Collette et al. (1996), who found
epitope (N-GAC ACC TAT CGC TAT ATA-C) into the 39 primer. The
a direct binding of recombinant expressed SH2/SH3 PCR product was cloned into the pRcCMV vector. To express an
domains of Lck to tyrosine-phosphorylated Nef and a N-terminal fragment of Nef in infected cells, an oligonucleotide cod-
proline-rich motif (PxxP motif) in the conserved central ing for an AU-1 tag (see above) followed by a stop codon was
introduced into the Xho site of the nef gene of the NL4-3 proviraldomain. It is not unlikely that several domains in Nef are
construct. The resulting recombinant viral clone was designatedinvolved in the binding of Lck, as reported for thebinding
NL4-3.nef.37.AU. To introduce the N-terminal Nef deletions into theof Hck to Nef (Saksela et al., 1995). We have observed
proviral NL4-3 clone, first a MluI restriction site was introduced in
that in COS cells Nef is hyperphosphorylatedon tyrosine between the env and nef open reading frames by PCR mutagenesis.
residues (data not shown). Therefore at least in COS Subsequently, the first 231 bp of NL4-3-Nef (MluI±KpnI) were re-
cells phosphorylated tyrosine residues, which are ab- moved and replaced with the corresponding region of SF2-Nef and
SF2-Nef mutants (D16±22 and D11±40), resulting in a chimeric nefsent in the N-terminus, could interact with the SH2 do-
gene of SF2 and NL4-3. The KpnI site is conserved in most nefmain of Lck. In T cells (Jurkat cells) we did not find Nef
sequences. A proviral construct without the MluI±KpnI insert, re-to be phosphorylated on tyrosine. This would explain
sulting in a N-terminal nef deletion, served as negative control. All
why in Jurkat cells an interaction of CN.47±211/CN.47± chimeric constructs and mutations were verified by dideoxynucleo-
100 with Lck was not observed (Figures 1 and 2). In tide sequencing. Expression plasmids for Lck andFyn were provided
line with the latter result, we could not confirm a direct by Joseph Bolen. All tyrosine kinases were expressed in the pSV7C
(Pharmacia) vector.association of recombinant Nef and Lck proteins. A simi-
lar observation was also reported by Saksela et al.
Cells, Antibodies, and Recombinant Proteins(1995).
Jurkat cell lines constitutively expressing truncated CD8 or CD8±NefBoth N-terminal Nef mutants (D16±22 and D11±40)
fusion proteins (SF2) were cultured in RPMI 1640 medium, 10%
retained their ability to down-regulate CD4 and bind fetal calf serum (FCS), geneticin at 500 mg/ml (G418; GIBCO BRL,
p62. This was not surprising since theN- and C-terminus Eggenstein, Federal Republic of Germany). COS-7 cells were grown
of Nef define distinguishable domains (Freund et al., in Dulbecco's minimal essential medium (DMEM) containing 10%
FCS. Jurkat, J.CaM.1, and J.CaM.1/lck cells were provided by Arthur1994a, 1994b; Lee et al., 1996) and both p62 and CD4
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Weiss. The anti-CD8 monoclonal antibody (MAb) OKT8, obtained the washed immunoprecipitates were resuspended in 50 ml of elu-
tion buffer (25 mM Tris±HCl [pH 7.5], 100 mM NaCl, 2 mM EDTA,from American Type Culture Collection, recognizes an extracellular
epitope of CD8 and was used at a concentration of 1 mg/ml. The 0.4% SDS, 2 mM 2-mercaptoethanol) and incubated at 958C for 2
min, causing the disruption of the protein±antibody complexes. Therabbit anti-SF2 Nef serum, raised against recombinant SF2-Nef pro-
tein, was provided by Patricia Olson (Chiron Corp., Emeryville, CA) protein A±Sepharose was then pelleted, the supernatant was trans-
ferred to a new tube, and iodoacetamide was added to a final con-and used at a 1:500 dilution. The anti-SIVmac239-Nef serum was pro-
vided by Paul Luciw. The anti-human Lck (IF-6, ascites; used at centration of 10 mM and incubated at 308C for 30 min in the dark.
Triton X-100 was added to final concentration of 2% and finally anti-1:105) antibody, as well as the recombinant GST±Lck, was a gift
from Joseph Bolen. The GST proteins were used at a concentration Lck antibodies andprotein A±Sepharose.The reimmunoprecipitates
(final volume of 250 ml) were rotated for 1 hr at 48C and subsequentlyof 1.0mg/ml. The MAb against phosphotyrosine (4G10) was obtained
from UBI (Lake Placid, NY) and used as recommended by the manu- processed as a regular immunoprecipitation (see above) before res-
olution on a SDS±polyacrylamide gel. For immunoblot analysis, im-facturer. The MAb against the AU-1 epitope was purchased from
Hiss-Diagnostics (Freiburg, Federal Republic of Germany). munoprecipitates were transferred to nitrocellulose followed by
Western blotting as described previously (Baur et al., 1994). To
visualize reactive bands, an enhanced chemiluminescence detec-
Transfections into T and COS Cells tion system was used (Amersham, Arlington Heights, IL). To deter-
The pCN expression plasmids were stably established in Jurkat mine the identity of the phosphorylated residues, phosphoamino
cells (clone E6) as described previously (Baur et al., 1994), using acid analyses were done on the phosphorylated substrates from
neomycin (G418; 2 mg/ml medium; GIBCO BRL) for selection. To the in vitro kinase assay, as described previously (Cooper et al.,
designate the resulting cell clones, a J. (for Jurkat) was added to the 1983). The nefgenes nef.4 and an unrelated protein (up; representing
respective name of the construct. For example,pCN.94 expressed in an unknown protein from a two-hybrid screen) were cloned into a
Jurkat cells resulted in a cell line termed J.CN.94. For transient pET vector (pET15b), expressed in E. coli (BL21), and purified under
transfections, 5 3 105 COS-7 were plated into 10 cm culture dishes native conditions through a histidine tag as described by the manu-
(Falcon). The next day, cells were washed once in PBS and incu- facturers (Novagen, Heidelberg; Clontech, Heidelberg). For purifica-
bated for approximately 2 hr in 4 ml of Opti-Mem low serum medium tion the Talon affinity resin was used (Clontech).
(GIBCO BRL) containing 5±10 mg of DNA (each plasmid) and 200
mg of DEAE±dextran. After transfection, the cells were washed once
Virus Stocks and Infectivity Assayin PBS before 10 ml of DMEM containing 10% FCS was added.
Jurkat cells (2 3 106) were transfected by electroporation with 20Following 48 hr of culture, the cells were harvested for in vitro kinase
mg of linearized proviral DNA. After 7 days of culture, supernatantsactivity. For the CD4 down-regulation assay, 3 mg of pSVCD4 (ex-
were assayedfor RTactivity. All proviral clones used yielded compa-pression plasmid for CD4 obtained from Waldemar Kolanus) along
rable RT values in the culture supernatant, which were subsequentlywith 3 mg of the respective pRcCMV-Nef expression plasmid or the
filtered and assayed/standardized for p24 antigen concentration.empty vector and 1 mg of pSVbGal expression plasmid (Clonetec)
For infection of resting PBMC, 2 3 106 PBMC from an adult donorwere cotransfected into COS cells. Cells were harvested after 2
were infected, in duplicates, with 2 ng p24 of wild-type and mutantdays by PBS/EDTA and subsequently stained with FITC-conjugated
viruses. The infected cells were then cultured for 2 days and subse-anti-CD4 by standard procedure and analyzed by FACS as de-
quently stimulated for 2 days with OKT3 (anti-CD3) at a concentra-scribed previously (Baur et al., 1994). One portion (about 10%) was
tion of 0.2 mg/ml. Thereafter, the cells were washed and cultureused to prepare cell lysates for bGal assays to verify comparable
supernatants were collected every second day for 2 weeks andtransfection efficiency.
subsequently tested for RT activity in 10 ml of supernatant.
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